The HER Pathway and Cancer
Dietmar Berger discusses the role of the HER2 receptor in metastatic breast cancer.
Array biopharma and Genentech's strategic alliance was voted Breakthrough Alliance of 2012. Partner with us.
Request for Research Materials
We support investigators in academia by supplying key reagents. Request proteins, antibodies, and cDNAs.
Genentech named FORTUNE Best Company
We've been named to FORTUNE's "100 Best Companies to Work For" list for the 16th year in a row.
From Our Labs
Genentech Cancer Genome Project scientists have identified ERBB3 somatic mutations in human cancers. Learn more and read our publication in Cancer Cell.
Call for Grants
Genentech is actively seeking applications for Independent Medical Education & Independent Research Projects.
The Genentech Research and Early Development pipeline has 30 new molecular entities in clinical development.
Meet our Scientists
Scientists are at the core of our business. Learn about what inspires them every day.
How We Work
Scientists know that the work they’re doing has a profound impact on people’s lives. In this video they talk about increasing the rate of success by turning failures into learning opportunities.
The RAS-RAF Pathway
Chris Bowden explains the RAS-RAF pathway, an important and evolving area of cancer research.
Scientific Research Board
An advisory group to the company around research and early development projects.
Our immunology program offers the experience needed to transform knowledge into practice
Support for Scientific Projects
We provide funding for general research, translational research, and other development projects.